nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCB1—Naltrexone—alcohol dependence	0.172	0.28	CbGbCtD
Atazanavir—CYP2C9—Disulfiram—alcohol dependence	0.165	0.268	CbGbCtD
Atazanavir—ABCB1—Citalopram—alcohol dependence	0.114	0.185	CbGbCtD
Atazanavir—CYP3A4—Disulfiram—alcohol dependence	0.0957	0.156	CbGbCtD
Atazanavir—CYP3A4—Citalopram—alcohol dependence	0.0682	0.111	CbGbCtD
Atazanavir—ABCB1—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.00372	0.074	CbGpPWpGaD
Atazanavir—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00296	0.059	CbGpPWpGaD
Atazanavir—SLCO1B3—Transport of organic anions—AVP—alcohol dependence	0.00295	0.0587	CbGpPWpGaD
Atazanavir—Ritonavir—CYP2E1—alcohol dependence	0.0023	1	CrCbGaD
Atazanavir—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.0019	0.0378	CbGpPWpGaD
Atazanavir—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00157	0.0313	CbGpPWpGaD
Atazanavir—ABCC1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—alcohol dependence	0.00142	0.0282	CbGpPWpGaD
Atazanavir—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00134	0.0266	CbGpPWpGaD
Atazanavir—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00115	0.0229	CbGpPWpGaD
Atazanavir—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00114	0.0226	CbGpPWpGaD
Atazanavir—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—AVP—alcohol dependence	0.00109	0.0218	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—PECR—alcohol dependence	0.00105	0.021	CbGpPWpGaD
Atazanavir—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.001	0.0199	CbGpPWpGaD
Atazanavir—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.000997	0.0199	CbGpPWpGaD
Atazanavir—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00095	0.0189	CbGpPWpGaD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00081	0.0161	CbGpPWpGaD
Atazanavir—Urinary tract infection—Naltrexone—alcohol dependence	0.000809	0.00243	CcSEcCtD
Atazanavir—Sleep disorder—Citalopram—alcohol dependence	0.000791	0.00237	CcSEcCtD
Atazanavir—Hepatitis—Acamprosate—alcohol dependence	0.00079	0.00237	CcSEcCtD
Atazanavir—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000787	0.00236	CcSEcCtD
Atazanavir—Diabetes mellitus—Citalopram—alcohol dependence	0.000787	0.00236	CcSEcCtD
Atazanavir—Hypoaesthesia—Acamprosate—alcohol dependence	0.000786	0.00236	CcSEcCtD
Atazanavir—Hallucination—Acamprosate—alcohol dependence	0.000786	0.00236	CcSEcCtD
Atazanavir—Polyuria—Citalopram—alcohol dependence	0.00078	0.00234	CcSEcCtD
Atazanavir—Oedema peripheral—Acamprosate—alcohol dependence	0.000778	0.00234	CcSEcCtD
Atazanavir—Gastroenteritis—Citalopram—alcohol dependence	0.000772	0.00232	CcSEcCtD
Atazanavir—Vascular purpura—Citalopram—alcohol dependence	0.000765	0.0023	CcSEcCtD
Atazanavir—Disorientation—Citalopram—alcohol dependence	0.000765	0.0023	CcSEcCtD
Atazanavir—Eczema—Citalopram—alcohol dependence	0.000762	0.00229	CcSEcCtD
Atazanavir—Dizziness—Disulfiram—alcohol dependence	0.000753	0.00226	CcSEcCtD
Atazanavir—Nasal congestion—Citalopram—alcohol dependence	0.000751	0.00225	CcSEcCtD
Atazanavir—Hepatitis—Naltrexone—alcohol dependence	0.000747	0.00224	CcSEcCtD
Atazanavir—Hallucination—Naltrexone—alcohol dependence	0.000744	0.00223	CcSEcCtD
Atazanavir—Libido decreased—Citalopram—alcohol dependence	0.000738	0.00222	CcSEcCtD
Atazanavir—Tinnitus—Acamprosate—alcohol dependence	0.000736	0.00221	CcSEcCtD
Atazanavir—Connective tissue disorder—Naltrexone—alcohol dependence	0.000734	0.0022	CcSEcCtD
Atazanavir—Increased appetite—Citalopram—alcohol dependence	0.000729	0.00219	CcSEcCtD
Atazanavir—Amnesia—Citalopram—alcohol dependence	0.000729	0.00219	CcSEcCtD
Atazanavir—Rash—Disulfiram—alcohol dependence	0.000718	0.00216	CcSEcCtD
Atazanavir—Dermatitis bullous—Citalopram—alcohol dependence	0.000716	0.00215	CcSEcCtD
Atazanavir—Headache—Disulfiram—alcohol dependence	0.000714	0.00214	CcSEcCtD
Atazanavir—Immune system disorder—Acamprosate—alcohol dependence	0.000713	0.00214	CcSEcCtD
Atazanavir—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.000712	0.0142	CbGpPWpGaD
Atazanavir—Purpura—Citalopram—alcohol dependence	0.00071	0.00213	CcSEcCtD
Atazanavir—ABCC1—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000707	0.0141	CbGpPWpGaD
Atazanavir—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000703	0.014	CbGpPWpGaD
Atazanavir—Hypoglycaemia—Citalopram—alcohol dependence	0.000701	0.0021	CcSEcCtD
Atazanavir—Eye disorder—Naltrexone—alcohol dependence	0.000698	0.0021	CcSEcCtD
Atazanavir—Alopecia—Acamprosate—alcohol dependence	0.000698	0.00209	CcSEcCtD
Atazanavir—Tinnitus—Naltrexone—alcohol dependence	0.000697	0.00209	CcSEcCtD
Atazanavir—Cardiac disorder—Naltrexone—alcohol dependence	0.000694	0.00208	CcSEcCtD
Atazanavir—Mental disorder—Acamprosate—alcohol dependence	0.000692	0.00208	CcSEcCtD
Atazanavir—Malnutrition—Acamprosate—alcohol dependence	0.000688	0.00206	CcSEcCtD
Atazanavir—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000685	0.0136	CbGpPWpGaD
Atazanavir—Pain in extremity—Citalopram—alcohol dependence	0.000685	0.00205	CcSEcCtD
Atazanavir—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000679	0.00204	CcSEcCtD
Atazanavir—Angiopathy—Naltrexone—alcohol dependence	0.000678	0.00203	CcSEcCtD
Atazanavir—Flatulence—Acamprosate—alcohol dependence	0.000678	0.00203	CcSEcCtD
Atazanavir—Immune system disorder—Naltrexone—alcohol dependence	0.000675	0.00203	CcSEcCtD
Atazanavir—Tension—Acamprosate—alcohol dependence	0.000675	0.00202	CcSEcCtD
Atazanavir—Affect lability—Citalopram—alcohol dependence	0.000674	0.00202	CcSEcCtD
Atazanavir—Mediastinal disorder—Naltrexone—alcohol dependence	0.000674	0.00202	CcSEcCtD
Atazanavir—Dysgeusia—Acamprosate—alcohol dependence	0.000673	0.00202	CcSEcCtD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000672	0.0134	CbGpPWpGaD
Atazanavir—Psychotic disorder—Citalopram—alcohol dependence	0.000669	0.00201	CcSEcCtD
Atazanavir—Nervousness—Acamprosate—alcohol dependence	0.000668	0.002	CcSEcCtD
Atazanavir—Back pain—Acamprosate—alcohol dependence	0.000665	0.002	CcSEcCtD
Atazanavir—Alopecia—Naltrexone—alcohol dependence	0.00066	0.00198	CcSEcCtD
Atazanavir—Mental disorder—Naltrexone—alcohol dependence	0.000655	0.00196	CcSEcCtD
Atazanavir—Cardiac arrest—Citalopram—alcohol dependence	0.000651	0.00195	CcSEcCtD
Atazanavir—Malnutrition—Naltrexone—alcohol dependence	0.000651	0.00195	CcSEcCtD
Atazanavir—Mood swings—Citalopram—alcohol dependence	0.000648	0.00195	CcSEcCtD
Atazanavir—Flatulence—Naltrexone—alcohol dependence	0.000641	0.00192	CcSEcCtD
Atazanavir—Tension—Naltrexone—alcohol dependence	0.000638	0.00192	CcSEcCtD
Atazanavir—Ill-defined disorder—Acamprosate—alcohol dependence	0.000638	0.00191	CcSEcCtD
Atazanavir—Dysgeusia—Naltrexone—alcohol dependence	0.000637	0.00191	CcSEcCtD
Atazanavir—Dehydration—Citalopram—alcohol dependence	0.000637	0.00191	CcSEcCtD
Atazanavir—Agitation—Acamprosate—alcohol dependence	0.000632	0.0019	CcSEcCtD
Atazanavir—Nervousness—Naltrexone—alcohol dependence	0.000632	0.0019	CcSEcCtD
Atazanavir—Back pain—Naltrexone—alcohol dependence	0.000629	0.00189	CcSEcCtD
Atazanavir—Angioedema—Acamprosate—alcohol dependence	0.000628	0.00189	CcSEcCtD
Atazanavir—Dry skin—Citalopram—alcohol dependence	0.000627	0.00188	CcSEcCtD
Atazanavir—Malaise—Acamprosate—alcohol dependence	0.00062	0.00186	CcSEcCtD
Atazanavir—Breast disorder—Citalopram—alcohol dependence	0.000619	0.00186	CcSEcCtD
Atazanavir—Syncope—Acamprosate—alcohol dependence	0.000617	0.00185	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000616	0.00185	CcSEcCtD
Atazanavir—Nasopharyngitis—Citalopram—alcohol dependence	0.000612	0.00184	CcSEcCtD
Atazanavir—Palpitations—Acamprosate—alcohol dependence	0.000608	0.00182	CcSEcCtD
Atazanavir—Gastritis—Citalopram—alcohol dependence	0.000606	0.00182	CcSEcCtD
Atazanavir—Loss of consciousness—Acamprosate—alcohol dependence	0.000604	0.00181	CcSEcCtD
Atazanavir—Muscular weakness—Citalopram—alcohol dependence	0.000604	0.00181	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000604	0.00181	CcSEcCtD
Atazanavir—Ill-defined disorder—Naltrexone—alcohol dependence	0.000604	0.00181	CcSEcCtD
Atazanavir—Cough—Acamprosate—alcohol dependence	0.0006	0.0018	CcSEcCtD
Atazanavir—Agitation—Naltrexone—alcohol dependence	0.000598	0.00179	CcSEcCtD
Atazanavir—Convulsion—Acamprosate—alcohol dependence	0.000596	0.00179	CcSEcCtD
Atazanavir—Abdominal distension—Citalopram—alcohol dependence	0.000596	0.00179	CcSEcCtD
Atazanavir—Angioedema—Naltrexone—alcohol dependence	0.000594	0.00178	CcSEcCtD
Atazanavir—Hypertension—Acamprosate—alcohol dependence	0.000594	0.00178	CcSEcCtD
Atazanavir—Malaise—Naltrexone—alcohol dependence	0.000587	0.00176	CcSEcCtD
Atazanavir—Eosinophilia—Citalopram—alcohol dependence	0.000586	0.00176	CcSEcCtD
Atazanavir—Arthralgia—Acamprosate—alcohol dependence	0.000585	0.00176	CcSEcCtD
Atazanavir—Myalgia—Acamprosate—alcohol dependence	0.000585	0.00176	CcSEcCtD
Atazanavir—Chest pain—Acamprosate—alcohol dependence	0.000585	0.00176	CcSEcCtD
Atazanavir—Syncope—Naltrexone—alcohol dependence	0.000583	0.00175	CcSEcCtD
Atazanavir—Anxiety—Acamprosate—alcohol dependence	0.000583	0.00175	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000581	0.00174	CcSEcCtD
Atazanavir—Pancreatitis—Citalopram—alcohol dependence	0.00058	0.00174	CcSEcCtD
Atazanavir—Discomfort—Acamprosate—alcohol dependence	0.000578	0.00174	CcSEcCtD
Atazanavir—Palpitations—Naltrexone—alcohol dependence	0.000575	0.00173	CcSEcCtD
Atazanavir—Dry mouth—Acamprosate—alcohol dependence	0.000573	0.00172	CcSEcCtD
Atazanavir—Loss of consciousness—Naltrexone—alcohol dependence	0.000572	0.00172	CcSEcCtD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000571	0.0114	CbGpPWpGaD
Atazanavir—Cough—Naltrexone—alcohol dependence	0.000568	0.0017	CcSEcCtD
Atazanavir—Confusional state—Acamprosate—alcohol dependence	0.000566	0.0017	CcSEcCtD
Atazanavir—Convulsion—Naltrexone—alcohol dependence	0.000564	0.00169	CcSEcCtD
Atazanavir—Hypertension—Naltrexone—alcohol dependence	0.000562	0.00169	CcSEcCtD
Atazanavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000562	0.0112	CbGpPWpGaD
Atazanavir—Infection—Acamprosate—alcohol dependence	0.000558	0.00167	CcSEcCtD
Atazanavir—Arthralgia—Naltrexone—alcohol dependence	0.000554	0.00166	CcSEcCtD
Atazanavir—Myalgia—Naltrexone—alcohol dependence	0.000554	0.00166	CcSEcCtD
Atazanavir—Chest pain—Naltrexone—alcohol dependence	0.000554	0.00166	CcSEcCtD
Atazanavir—Shock—Acamprosate—alcohol dependence	0.000552	0.00166	CcSEcCtD
Atazanavir—Anxiety—Naltrexone—alcohol dependence	0.000552	0.00166	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00055	0.00165	CcSEcCtD
Atazanavir—Discomfort—Naltrexone—alcohol dependence	0.000547	0.00164	CcSEcCtD
Atazanavir—Pollakiuria—Citalopram—alcohol dependence	0.000547	0.00164	CcSEcCtD
Atazanavir—Skin disorder—Acamprosate—alcohol dependence	0.000545	0.00164	CcSEcCtD
Atazanavir—Erectile dysfunction—Citalopram—alcohol dependence	0.000545	0.00164	CcSEcCtD
Atazanavir—Hyperhidrosis—Acamprosate—alcohol dependence	0.000543	0.00163	CcSEcCtD
Atazanavir—Dry mouth—Naltrexone—alcohol dependence	0.000542	0.00163	CcSEcCtD
Atazanavir—Photosensitivity reaction—Citalopram—alcohol dependence	0.00054	0.00162	CcSEcCtD
Atazanavir—Weight increased—Citalopram—alcohol dependence	0.000538	0.00162	CcSEcCtD
Atazanavir—Confusional state—Naltrexone—alcohol dependence	0.000535	0.00161	CcSEcCtD
Atazanavir—Weight decreased—Citalopram—alcohol dependence	0.000535	0.00161	CcSEcCtD
Atazanavir—Anorexia—Acamprosate—alcohol dependence	0.000535	0.00161	CcSEcCtD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000535	0.0106	CbGpPWpGaD
Atazanavir—Hyperglycaemia—Citalopram—alcohol dependence	0.000534	0.0016	CcSEcCtD
Atazanavir—Oedema—Naltrexone—alcohol dependence	0.000531	0.00159	CcSEcCtD
Atazanavir—Infection—Naltrexone—alcohol dependence	0.000528	0.00158	CcSEcCtD
Atazanavir—Depression—Citalopram—alcohol dependence	0.000526	0.00158	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000523	0.00157	CcSEcCtD
Atazanavir—Shock—Naltrexone—alcohol dependence	0.000522	0.00157	CcSEcCtD
Atazanavir—Nervous system disorder—Naltrexone—alcohol dependence	0.000521	0.00156	CcSEcCtD
Atazanavir—Neuropathy peripheral—Citalopram—alcohol dependence	0.000517	0.00155	CcSEcCtD
Atazanavir—Skin disorder—Naltrexone—alcohol dependence	0.000516	0.00155	CcSEcCtD
Atazanavir—Stomatitis—Citalopram—alcohol dependence	0.000514	0.00154	CcSEcCtD
Atazanavir—Jaundice—Citalopram—alcohol dependence	0.000514	0.00154	CcSEcCtD
Atazanavir—Hyperhidrosis—Naltrexone—alcohol dependence	0.000513	0.00154	CcSEcCtD
Atazanavir—Urinary tract infection—Citalopram—alcohol dependence	0.000513	0.00154	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000511	0.00153	CcSEcCtD
Atazanavir—Insomnia—Acamprosate—alcohol dependence	0.000508	0.00152	CcSEcCtD
Atazanavir—Anorexia—Naltrexone—alcohol dependence	0.000506	0.00152	CcSEcCtD
Atazanavir—Sweating—Citalopram—alcohol dependence	0.000506	0.00152	CcSEcCtD
Atazanavir—Haematuria—Citalopram—alcohol dependence	0.000503	0.00151	CcSEcCtD
Atazanavir—Dyspnoea—Acamprosate—alcohol dependence	0.0005	0.0015	CcSEcCtD
Atazanavir—Somnolence—Acamprosate—alcohol dependence	0.000499	0.0015	CcSEcCtD
Atazanavir—Hepatobiliary disease—Citalopram—alcohol dependence	0.000499	0.0015	CcSEcCtD
Atazanavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000499	0.00993	CbGpPWpGaD
Atazanavir—Dyspepsia—Acamprosate—alcohol dependence	0.000494	0.00148	CcSEcCtD
Atazanavir—Decreased appetite—Acamprosate—alcohol dependence	0.000488	0.00146	CcSEcCtD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000486	0.00967	CbGpPWpGaD
Atazanavir—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000485	0.00145	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000484	0.00145	CcSEcCtD
Atazanavir—Insomnia—Naltrexone—alcohol dependence	0.00048	0.00144	CcSEcCtD
Atazanavir—Constipation—Acamprosate—alcohol dependence	0.00048	0.00144	CcSEcCtD
Atazanavir—Pain—Acamprosate—alcohol dependence	0.00048	0.00144	CcSEcCtD
Atazanavir—Hepatitis—Citalopram—alcohol dependence	0.000474	0.00142	CcSEcCtD
Atazanavir—Dyspnoea—Naltrexone—alcohol dependence	0.000473	0.00142	CcSEcCtD
Atazanavir—Somnolence—Naltrexone—alcohol dependence	0.000472	0.00142	CcSEcCtD
Atazanavir—Hallucination—Citalopram—alcohol dependence	0.000471	0.00141	CcSEcCtD
Atazanavir—Hypoaesthesia—Citalopram—alcohol dependence	0.000471	0.00141	CcSEcCtD
Atazanavir—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.00047	0.00936	CbGpPWpGaD
Atazanavir—Urinary tract disorder—Citalopram—alcohol dependence	0.000468	0.0014	CcSEcCtD
Atazanavir—Oedema peripheral—Citalopram—alcohol dependence	0.000466	0.0014	CcSEcCtD
Atazanavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000466	0.00928	CbGpPWpGaD
Atazanavir—Connective tissue disorder—Citalopram—alcohol dependence	0.000465	0.0014	CcSEcCtD
Atazanavir—Urethral disorder—Citalopram—alcohol dependence	0.000464	0.00139	CcSEcCtD
Atazanavir—Feeling abnormal—Acamprosate—alcohol dependence	0.000462	0.00139	CcSEcCtD
Atazanavir—Decreased appetite—Naltrexone—alcohol dependence	0.000462	0.00139	CcSEcCtD
Atazanavir—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000459	0.00138	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000458	0.00138	CcSEcCtD
Atazanavir—Fatigue—Naltrexone—alcohol dependence	0.000458	0.00137	CcSEcCtD
Atazanavir—Pain—Naltrexone—alcohol dependence	0.000454	0.00136	CcSEcCtD
Atazanavir—Constipation—Naltrexone—alcohol dependence	0.000454	0.00136	CcSEcCtD
Atazanavir—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000452	0.009	CbGpPWpGaD
Atazanavir—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000449	0.00895	CbGpPWpGaD
Atazanavir—Erythema multiforme—Citalopram—alcohol dependence	0.000448	0.00134	CcSEcCtD
Atazanavir—Urticaria—Acamprosate—alcohol dependence	0.000446	0.00134	CcSEcCtD
Atazanavir—Abdominal pain—Acamprosate—alcohol dependence	0.000444	0.00133	CcSEcCtD
Atazanavir—Body temperature increased—Acamprosate—alcohol dependence	0.000444	0.00133	CcSEcCtD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000443	0.00882	CbGpPWpGaD
Atazanavir—Eye disorder—Citalopram—alcohol dependence	0.000443	0.00133	CcSEcCtD
Atazanavir—Tinnitus—Citalopram—alcohol dependence	0.000442	0.00132	CcSEcCtD
Atazanavir—Cardiac disorder—Citalopram—alcohol dependence	0.000439	0.00132	CcSEcCtD
Atazanavir—Feeling abnormal—Naltrexone—alcohol dependence	0.000438	0.00131	CcSEcCtD
Atazanavir—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000434	0.0013	CcSEcCtD
Atazanavir—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000431	0.00857	CbGpPWpGaD
Atazanavir—Angiopathy—Citalopram—alcohol dependence	0.00043	0.00129	CcSEcCtD
Atazanavir—Immune system disorder—Citalopram—alcohol dependence	0.000428	0.00128	CcSEcCtD
Atazanavir—Mediastinal disorder—Citalopram—alcohol dependence	0.000427	0.00128	CcSEcCtD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000426	0.00848	CbGpPWpGaD
Atazanavir—Urticaria—Naltrexone—alcohol dependence	0.000422	0.00127	CcSEcCtD
Atazanavir—Abdominal pain—Naltrexone—alcohol dependence	0.00042	0.00126	CcSEcCtD
Atazanavir—Body temperature increased—Naltrexone—alcohol dependence	0.00042	0.00126	CcSEcCtD
Atazanavir—Alopecia—Citalopram—alcohol dependence	0.000418	0.00126	CcSEcCtD
Atazanavir—Mental disorder—Citalopram—alcohol dependence	0.000415	0.00124	CcSEcCtD
Atazanavir—Hypersensitivity—Acamprosate—alcohol dependence	0.000413	0.00124	CcSEcCtD
Atazanavir—Malnutrition—Citalopram—alcohol dependence	0.000412	0.00124	CcSEcCtD
Atazanavir—Flatulence—Citalopram—alcohol dependence	0.000406	0.00122	CcSEcCtD
Atazanavir—Tension—Citalopram—alcohol dependence	0.000405	0.00121	CcSEcCtD
Atazanavir—Dysgeusia—Citalopram—alcohol dependence	0.000404	0.00121	CcSEcCtD
Atazanavir—Asthenia—Acamprosate—alcohol dependence	0.000403	0.00121	CcSEcCtD
Atazanavir—Nervousness—Citalopram—alcohol dependence	0.0004	0.0012	CcSEcCtD
Atazanavir—Back pain—Citalopram—alcohol dependence	0.000399	0.0012	CcSEcCtD
Atazanavir—Pruritus—Acamprosate—alcohol dependence	0.000397	0.00119	CcSEcCtD
Atazanavir—Hypersensitivity—Naltrexone—alcohol dependence	0.000391	0.00117	CcSEcCtD
Atazanavir—Diarrhoea—Acamprosate—alcohol dependence	0.000384	0.00115	CcSEcCtD
Atazanavir—Ill-defined disorder—Citalopram—alcohol dependence	0.000382	0.00115	CcSEcCtD
Atazanavir—Asthenia—Naltrexone—alcohol dependence	0.000381	0.00114	CcSEcCtD
Atazanavir—Agitation—Citalopram—alcohol dependence	0.000379	0.00114	CcSEcCtD
Atazanavir—Angioedema—Citalopram—alcohol dependence	0.000377	0.00113	CcSEcCtD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000377	0.0075	CbGpPWpGaD
Atazanavir—Pruritus—Naltrexone—alcohol dependence	0.000376	0.00113	CcSEcCtD
Atazanavir—Malaise—Citalopram—alcohol dependence	0.000372	0.00112	CcSEcCtD
Atazanavir—Dizziness—Acamprosate—alcohol dependence	0.000371	0.00111	CcSEcCtD
Atazanavir—Syncope—Citalopram—alcohol dependence	0.00037	0.00111	CcSEcCtD
Atazanavir—Palpitations—Citalopram—alcohol dependence	0.000364	0.00109	CcSEcCtD
Atazanavir—Diarrhoea—Naltrexone—alcohol dependence	0.000363	0.00109	CcSEcCtD
Atazanavir—Loss of consciousness—Citalopram—alcohol dependence	0.000362	0.00109	CcSEcCtD
Atazanavir—Cough—Citalopram—alcohol dependence	0.00036	0.00108	CcSEcCtD
Atazanavir—Convulsion—Citalopram—alcohol dependence	0.000357	0.00107	CcSEcCtD
Atazanavir—Vomiting—Acamprosate—alcohol dependence	0.000357	0.00107	CcSEcCtD
Atazanavir—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000357	0.0071	CbGpPWpGaD
Atazanavir—Hypertension—Citalopram—alcohol dependence	0.000356	0.00107	CcSEcCtD
Atazanavir—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000355	0.00707	CbGpPWpGaD
Atazanavir—Rash—Acamprosate—alcohol dependence	0.000354	0.00106	CcSEcCtD
Atazanavir—Dermatitis—Acamprosate—alcohol dependence	0.000354	0.00106	CcSEcCtD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000353	0.00703	CbGpPWpGaD
Atazanavir—Headache—Acamprosate—alcohol dependence	0.000352	0.00105	CcSEcCtD
Atazanavir—Dizziness—Naltrexone—alcohol dependence	0.000351	0.00105	CcSEcCtD
Atazanavir—Arthralgia—Citalopram—alcohol dependence	0.000351	0.00105	CcSEcCtD
Atazanavir—Chest pain—Citalopram—alcohol dependence	0.000351	0.00105	CcSEcCtD
Atazanavir—Myalgia—Citalopram—alcohol dependence	0.000351	0.00105	CcSEcCtD
Atazanavir—Anxiety—Citalopram—alcohol dependence	0.00035	0.00105	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000349	0.00105	CcSEcCtD
Atazanavir—Discomfort—Citalopram—alcohol dependence	0.000347	0.00104	CcSEcCtD
Atazanavir—Dry mouth—Citalopram—alcohol dependence	0.000343	0.00103	CcSEcCtD
Atazanavir—Confusional state—Citalopram—alcohol dependence	0.000339	0.00102	CcSEcCtD
Atazanavir—Vomiting—Naltrexone—alcohol dependence	0.000338	0.00101	CcSEcCtD
Atazanavir—Oedema—Citalopram—alcohol dependence	0.000336	0.00101	CcSEcCtD
Atazanavir—Rash—Naltrexone—alcohol dependence	0.000335	0.001	CcSEcCtD
Atazanavir—Dermatitis—Naltrexone—alcohol dependence	0.000334	0.001	CcSEcCtD
Atazanavir—Infection—Citalopram—alcohol dependence	0.000334	0.001	CcSEcCtD
Atazanavir—Nausea—Acamprosate—alcohol dependence	0.000333	0.001	CcSEcCtD
Atazanavir—Headache—Naltrexone—alcohol dependence	0.000333	0.000998	CcSEcCtD
Atazanavir—Shock—Citalopram—alcohol dependence	0.000331	0.000993	CcSEcCtD
Atazanavir—Nervous system disorder—Citalopram—alcohol dependence	0.00033	0.00099	CcSEcCtD
Atazanavir—Skin disorder—Citalopram—alcohol dependence	0.000327	0.000981	CcSEcCtD
Atazanavir—Hyperhidrosis—Citalopram—alcohol dependence	0.000325	0.000976	CcSEcCtD
Atazanavir—Anorexia—Citalopram—alcohol dependence	0.000321	0.000962	CcSEcCtD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00032	0.00638	CbGpPWpGaD
Atazanavir—Nausea—Naltrexone—alcohol dependence	0.000315	0.000946	CcSEcCtD
Atazanavir—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000314	0.00626	CbGpPWpGaD
Atazanavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000307	0.00612	CbGpPWpGaD
Atazanavir—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000307	0.00092	CcSEcCtD
Atazanavir—Insomnia—Citalopram—alcohol dependence	0.000304	0.000913	CcSEcCtD
Atazanavir—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000303	0.00604	CbGpPWpGaD
Atazanavir—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000302	0.00601	CbGpPWpGaD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.0003	0.00597	CbGpPWpGaD
Atazanavir—Dyspnoea—Citalopram—alcohol dependence	0.0003	0.0009	CcSEcCtD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.0003	0.00597	CbGpPWpGaD
Atazanavir—Somnolence—Citalopram—alcohol dependence	0.000299	0.000897	CcSEcCtD
Atazanavir—Dyspepsia—Citalopram—alcohol dependence	0.000296	0.000889	CcSEcCtD
Atazanavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000296	0.00589	CbGpPWpGaD
Atazanavir—Decreased appetite—Citalopram—alcohol dependence	0.000292	0.000878	CcSEcCtD
Atazanavir—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000292	0.00581	CbGpPWpGaD
Atazanavir—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00029	0.000872	CcSEcCtD
Atazanavir—Fatigue—Citalopram—alcohol dependence	0.00029	0.00087	CcSEcCtD
Atazanavir—Pain—Citalopram—alcohol dependence	0.000288	0.000863	CcSEcCtD
Atazanavir—Constipation—Citalopram—alcohol dependence	0.000288	0.000863	CcSEcCtD
Atazanavir—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000284	0.00565	CbGpPWpGaD
Atazanavir—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000284	0.00565	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000281	0.00559	CbGpPWpGaD
Atazanavir—Feeling abnormal—Citalopram—alcohol dependence	0.000277	0.000832	CcSEcCtD
Atazanavir—Gastrointestinal pain—Citalopram—alcohol dependence	0.000275	0.000826	CcSEcCtD
Atazanavir—Urticaria—Citalopram—alcohol dependence	0.000267	0.000802	CcSEcCtD
Atazanavir—Abdominal pain—Citalopram—alcohol dependence	0.000266	0.000798	CcSEcCtD
Atazanavir—Body temperature increased—Citalopram—alcohol dependence	0.000266	0.000798	CcSEcCtD
Atazanavir—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000258	0.00514	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000255	0.00508	CbGpPWpGaD
Atazanavir—Hypersensitivity—Citalopram—alcohol dependence	0.000248	0.000744	CcSEcCtD
Atazanavir—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000247	0.00492	CbGpPWpGaD
Atazanavir—Asthenia—Citalopram—alcohol dependence	0.000241	0.000724	CcSEcCtD
Atazanavir—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000241	0.00481	CbGpPWpGaD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00024	0.00478	CbGpPWpGaD
Atazanavir—Pruritus—Citalopram—alcohol dependence	0.000238	0.000714	CcSEcCtD
Atazanavir—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000235	0.00469	CbGpPWpGaD
Atazanavir—SLCO1B3—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000235	0.00468	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ADH6—alcohol dependence	0.000234	0.00467	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000233	0.00463	CbGpPWpGaD
Atazanavir—Diarrhoea—Citalopram—alcohol dependence	0.00023	0.000691	CcSEcCtD
Atazanavir—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000226	0.0045	CbGpPWpGaD
Atazanavir—Dizziness—Citalopram—alcohol dependence	0.000222	0.000668	CcSEcCtD
Atazanavir—Vomiting—Citalopram—alcohol dependence	0.000214	0.000642	CcSEcCtD
Atazanavir—Rash—Citalopram—alcohol dependence	0.000212	0.000637	CcSEcCtD
Atazanavir—Dermatitis—Citalopram—alcohol dependence	0.000212	0.000636	CcSEcCtD
Atazanavir—ABCC1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000212	0.00422	CbGpPWpGaD
Atazanavir—Headache—Citalopram—alcohol dependence	0.000211	0.000632	CcSEcCtD
Atazanavir—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.0002	0.00398	CbGpPWpGaD
Atazanavir—Nausea—Citalopram—alcohol dependence	0.0002	0.0006	CcSEcCtD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000198	0.00394	CbGpPWpGaD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000197	0.00393	CbGpPWpGaD
Atazanavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000195	0.00389	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ADH1A—alcohol dependence	0.000194	0.00387	CbGpPWpGaD
Atazanavir—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000193	0.00383	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000187	0.00373	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.00018	0.00359	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.00017	0.00339	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ADH6—alcohol dependence	0.000166	0.0033	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ADH4—alcohol dependence	0.000165	0.00329	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000163	0.00325	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000159	0.00317	CbGpPWpGaD
Atazanavir—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000158	0.00316	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000158	0.00315	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000149	0.00297	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000144	0.00287	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000143	0.00285	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ADH7—alcohol dependence	0.00014	0.0028	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ADH1A—alcohol dependence	0.000137	0.00273	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GGT2—alcohol dependence	0.000135	0.00268	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00013	0.00259	CbGpPWpGaD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000128	0.00256	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000127	0.00254	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000126	0.0025	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000124	0.00246	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ADH1B—alcohol dependence	0.000123	0.00245	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000119	0.00238	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000117	0.00233	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ADH4—alcohol dependence	0.000117	0.00232	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000105	0.00209	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000105	0.00209	CbGpPWpGaD
Atazanavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000104	0.00208	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000104	0.00208	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MAOB—alcohol dependence	0.000102	0.00203	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000102	0.00203	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000101	0.00201	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000101	0.00201	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ADH7—alcohol dependence	9.92e-05	0.00198	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GGT2—alcohol dependence	9.51e-05	0.00189	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ADH1B—alcohol dependence	8.7e-05	0.00173	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALDH2—alcohol dependence	8.67e-05	0.00173	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	8.57e-05	0.00171	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	8.47e-05	0.00169	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—AVP—alcohol dependence	8.44e-05	0.00168	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	8.4e-05	0.00167	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	8.34e-05	0.00166	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	8.29e-05	0.00165	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADH6—alcohol dependence	7.88e-05	0.00157	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GGT1—alcohol dependence	7.71e-05	0.00154	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GOT2—alcohol dependence	7.37e-05	0.00147	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADH6—alcohol dependence	7.36e-05	0.00147	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MAOB—alcohol dependence	7.21e-05	0.00144	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP2E1—alcohol dependence	6.93e-05	0.00138	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—MAOA—alcohol dependence	6.91e-05	0.00138	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—POMC—alcohol dependence	6.82e-05	0.00136	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADH1A—alcohol dependence	6.53e-05	0.0013	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GGT1—alcohol dependence	6.37e-05	0.00127	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GOT1—alcohol dependence	6.37e-05	0.00127	CbGpPWpGaD
Atazanavir—ABCC1—Disease—GOT2—alcohol dependence	6.23e-05	0.00124	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALDH2—alcohol dependence	6.13e-05	0.00122	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADH1A—alcohol dependence	6.1e-05	0.00121	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	5.9e-05	0.00117	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MAOA—alcohol dependence	5.7e-05	0.00114	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADH4—alcohol dependence	5.55e-05	0.00111	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	5.53e-05	0.0011	CbGpPWpGaD
Atazanavir—ABCC1—Disease—GOT1—alcohol dependence	5.37e-05	0.00107	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GOT2—alcohol dependence	5.21e-05	0.00104	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADH4—alcohol dependence	5.19e-05	0.00103	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP2E1—alcohol dependence	4.9e-05	0.000976	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADH6—alcohol dependence	4.86e-05	0.000967	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	4.85e-05	0.000966	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADH7—alcohol dependence	4.72e-05	0.00094	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GGT2—alcohol dependence	4.53e-05	0.000901	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GOT1—alcohol dependence	4.5e-05	0.000896	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GGT1—alcohol dependence	4.5e-05	0.000896	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—POMC—alcohol dependence	4.5e-05	0.000896	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	4.49e-05	0.000894	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	4.46e-05	0.000887	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADH7—alcohol dependence	4.41e-05	0.000878	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GGT2—alcohol dependence	4.23e-05	0.000842	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADH1B—alcohol dependence	4.14e-05	0.000825	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MAOA—alcohol dependence	4.03e-05	0.000803	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADH1A—alcohol dependence	4.02e-05	0.000801	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	4.01e-05	0.000799	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.91e-05	0.000779	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADH1B—alcohol dependence	3.87e-05	0.00077	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—POMC—alcohol dependence	3.71e-05	0.00074	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MAOB—alcohol dependence	3.43e-05	0.000683	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADH4—alcohol dependence	3.42e-05	0.000681	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MAOB—alcohol dependence	3.2e-05	0.000638	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDH2—alcohol dependence	2.92e-05	0.000581	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADH7—alcohol dependence	2.91e-05	0.000579	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GGT2—alcohol dependence	2.79e-05	0.000555	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDH2—alcohol dependence	2.72e-05	0.000543	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—POMC—alcohol dependence	2.63e-05	0.000523	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.62e-05	0.000522	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.55e-05	0.000508	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GOT2—alcohol dependence	2.48e-05	0.000494	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—EP300—alcohol dependence	2.46e-05	0.000491	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2E1—alcohol dependence	2.33e-05	0.000464	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GOT2—alcohol dependence	2.32e-05	0.000461	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2E1—alcohol dependence	2.18e-05	0.000434	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GOT1—alcohol dependence	2.14e-05	0.000426	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GGT1—alcohol dependence	2.14e-05	0.000426	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MAOB—alcohol dependence	2.11e-05	0.000421	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EP300—alcohol dependence	2.08e-05	0.000414	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GGT1—alcohol dependence	2e-05	0.000398	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GOT1—alcohol dependence	2e-05	0.000398	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MAOA—alcohol dependence	1.92e-05	0.000382	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.8e-05	0.000358	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MAOA—alcohol dependence	1.79e-05	0.000357	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—EP300—alcohol dependence	1.74e-05	0.000347	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.74e-05	0.000346	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GOT2—alcohol dependence	1.53e-05	0.000304	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.44e-05	0.000286	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GOT1—alcohol dependence	1.32e-05	0.000263	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GGT1—alcohol dependence	1.32e-05	0.000263	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—POMC—alcohol dependence	1.25e-05	0.000249	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MAOA—alcohol dependence	1.18e-05	0.000235	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—POMC—alcohol dependence	1.17e-05	0.000232	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—EP300—alcohol dependence	8.29e-06	0.000165	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—EP300—alcohol dependence	7.74e-06	0.000154	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—POMC—alcohol dependence	7.7e-06	0.000153	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—EP300—alcohol dependence	5.11e-06	0.000102	CbGpPWpGaD
